Reinhold Schilling

Reinhold Schilling has a diverse work experience in the pharmaceutical industry, with expertise in pharmacovigilance, regulatory affairs, and safety management. Reinhold started their career as a Drug Safety Junior Manager at UCB Pharma GmbH, where they were responsible for evaluating adverse events and participating in training events. Reinhold then worked at MUCOS Pharma GmbH & Co. KG as a Manager of Regulatory Affairs, handling new registrations and variations for national approvals. Schilling later joined Omega Pharma, A Perrigo Company, holding various positions such as Senior Safety Manager, Team Lead Patient Safety & Consumer Service, and Senior Manager Regulatory Affairs. In these roles, they managed regulatory activities, ensured compliance, and communicated with local authorities. Reinhold also served as a Head of Global Pharmacovigilance, EU Qualified Person for Pharmacovigilance, and Stufenplanbeauftragter at both Wörwag Pharma GmbH & Co. KG and AAA-Pharma GmbH. In these positions, they supervised and managed pharmacovigilance activities, maintained compliance with applicable laws and regulations, and oversaw risk management and signal detection. Overall, Schilling has a wealth of experience in ensuring the safety and compliance of pharmaceutical products.

Reinhold Schilling has a Master's degree in Drug Regulatory Affairs from The University of Bonn, which they obtained from 2013 to 2015. Prior to that, they earned a Diplom degree in Chemie from Rheinische Friedrich-Wilhelms-Universität between 2004 and 2011. In addition to their formal education, Reinhold has obtained various certifications in areas such as project management, delegating tasks, moderating meetings, change management, Six Sigma fundamentals, team building and leadership. These certifications were gained from LinkedIn and obtained between 2020 and 2021.